Epidemiology of non-multiresistant methicillin-resistant Staphylococcus aureus infection in Queensland, Australia: associations with indigenous populations and Panton–Valentine leukocidin

  • G. R. Nimmo
  • J. M. Schooneveldt
  • J. L. Sutherland
  • S. Power
  • D. Olesen
  • C. Selvey
  • F. Beard
  • M. Jones
  • D. L. Paterson
Article

Abstract

The purpose of this study was to determine the extent of the spread of epidemic clones of non-multiresistant methicillin-resistant Staphylococcus aureus (nmMRSA) and the epidemiology of resultant infections throughout the state of Queensland. We collected a sample of clinical isolates of nmMRSA from laboratories serving public hospitals and clinics throughout the state. Three hundred isolates were typed and tested for the presence of Panton–Valentine leukocidin (PVL) genes and demographic and clinical data were collected from associated cases. Fifteen percent of S. aureus isolates were nmMRSA and 69% of these belonged to PVL-positive clones, predominantly ST93 and CC30. Low numbers of USA300- and USA400-like isolates were also present. Infections due to PVL-positive strains were much less frequently acquired in hospital (3.4%) than those due to PVL-negative nmMRSA (23.7%). Thirty-seven percent of cases were in indigenous people who make up only 3.6% of the general population. The proportion of cases with PVL-positive, but non-negative isolates decreased progressively with age, suggesting that immunity to PVL might be an important determinant of protection. nmMRSA strains are present throughout Queensland and cause infections in both community and healthcare settings.

References

  1. 1.
    Collignon P, Gosbell I, Vickery A, Nimmo G, Stylianopoulos T, Gottlieb T (1998) Community-acquired meticillin-resistant Staphylococcus aureus in Australia. Lancet 352:145–146CrossRefPubMedGoogle Scholar
  2. 2.
    Nimmo GR, Schooneveldt J, O'Kane G, McCall B, Vickery A (2000) Community acquisition of gentamicin-sensitive MRSA in south-east Queensland. J Clin Microbiol 38:3926–3931PubMedGoogle Scholar
  3. 3.
    Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H et al (2003) Community-acquired methicillin resistant Staphylococcus aureus carrying Panton-Valentine Leukocidin genes: worldwide emergence. Emerg Infect Dis 9:978–984PubMedGoogle Scholar
  4. 4.
    Munckhof WJ, Schooneveldt J, Coombs GW, Hoare J, Nimmo GR (2003) Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, Australia. Int J Infect Dis 7(4):259–267CrossRefPubMedGoogle Scholar
  5. 5.
    Coombs GW, Nimmo GR, Bell JM, Huygens F, O’Brien FG, Malkowski MJ et al (2004) Community methicillin-resistant Staphylococcus aureus in Australia: genetic diversity in strains causing outpatient infections. J Clin Microbiol 42(10):4735–4743CrossRefPubMedGoogle Scholar
  6. 6.
    Vlack S, Cox L, Peleg AY, Canuto C, Stewart C, Conlon A et al (2006) Carriage of methicillin-resistant Staphylococcus aureus in a Queensland Indigenous community. Med J Aust 184(11):556–559PubMedGoogle Scholar
  7. 7.
    Australian Bureaux of Statistics (2006) Census tables: Commonwealth of Australia; 2007Google Scholar
  8. 8.
    Munckhof WJ, Nimmo GR, Carney J, Schooneveldt JM, Huygens F, Inman-Bamber J et al (2008) Methicillin-susceptible, non-multiresistant methicillin-resistant and multiresistant methicillin-resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study. Eur J Clin Microbiol Infect Dis 27:355–364CrossRefPubMedGoogle Scholar
  9. 9.
    Peleg AY, Munckhof WJ, Kleinschmidt SL, Stephens AJ, Huygens F (2005) Life-threatening community-acquired methicillin-resistant Staphylococcus aureus infection in Australia. Eur J Clin Microbiol Infect Dis 24(6):384–387CrossRefPubMedGoogle Scholar
  10. 10.
    Risson DC, O’Connor ED (2007) R.W. G, Schooneveldt JM, Nimmo GR. A rapidly fatal case of necrotising pneumonia due to community-associated methicillin-resistant Staphylococcus aureus. Med J Aust 186(9):479–480PubMedGoogle Scholar
  11. 11.
    Nimmo GR, Fong J, Paterson DL, McLaws ML (2008) Changing epidemiology of meticillin-resistant S. aureus in Queensland, Australia, 2000–2006: use of passive surveillance of susceptibility phenotypes. J Hosp Infect 70(4):305–313CrossRefPubMedGoogle Scholar
  12. 12.
    Nimmo GR, Coombs GW, Pearson PC, O'Brien FG, Christiansen KJ, Turnidge JD et al (2006) MRSA in the Australian community: an evolving epidemic. Med J Aust 184:384–388PubMedGoogle Scholar
  13. 13.
    Gonzalez BE, Rueda AM, Shelburne SA 3rd, Musher DM, Hamill RJ, Hulten KG (2006) Community-associated strains of methicillin-resistant Staphylococcus aureus as the cause of healthcare-associated infection. Infect Control Hosp Epidemiol 27(10):1051–1056CrossRefPubMedGoogle Scholar
  14. 14.
    McCaskill ML, Mason EO Jr, Kaplan SL, Hammerman W, Lamberth LB, Hulten KG (2007) Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J 26(12):1122–1127CrossRefPubMedGoogle Scholar
  15. 15.
    Tietz A, Frei R, Widmer AF (2005) Transatlantic spread of the USA300 clone of MRSA. N Engl J Med 353(5):532–533CrossRefPubMedGoogle Scholar
  16. 16.
    Huygens F, Inman-Bamber J, Nimmo GR, Munckhof W, Schooneveldt J, Harrison B et al (2006) Staphylococcus aureus genotyping using novel real-time PCR formats. J Clin Microbiol 44(10):3712–3719CrossRefPubMedGoogle Scholar
  17. 17.
    Nimmo GR, Pearson JC, Collignon PJ, Christiansen KJ, Coombs GW, Bell JM et al (2007) Prevalence of MRSA among Staphylococcus aureus isolated from Hospital inpatients, 2005: report from the Australian Group for Antimicrobial Resistance. Commun Dis Intell 31:398–403PubMedGoogle Scholar
  18. 18.
    Coombs G, Pearson J, Christiansen K, Nimmo G (2008) Staphylococcus aureus programme 2006 community survey MRSA epidemiology and typing report: Australian group for antimicrobial resistance. http://www.agargroup.org/surveys. Accessed 2 February 2010
  19. 19.
    Munckhof WJ, Krishnan A, Kruger P, Looke D (2008) Cavernous sinus thrombosis and meningitis from community-acquired methicillin-resistant Staphylococcus aureus infection. Intern Med J 38(4):283–287CrossRefPubMedGoogle Scholar
  20. 20.
    Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V et al (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29(5):1128–1132CrossRefPubMedGoogle Scholar
  21. 21.
    Genestier AL, Michallet MC, Prevost G, Bellot G, Chalabreysse L, Peyrol S et al (2005) Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 115(11):3117–3127CrossRefPubMedGoogle Scholar
  22. 22.
    Labandeira-Rey M, Couzon F, Boisset S, Brown EL, Bes M, Benito Y et al (2007) Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 315(5815):1130–1133CrossRefPubMedGoogle Scholar
  23. 23.
    Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D et al (2006) Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 194(12):1761–1770CrossRefPubMedGoogle Scholar
  24. 24.
    Löffler B, Hussain M, Grundmeier M, Brück M, Holzinger D, Varga G, Roth J, Kahl BC, Proctor RA, Peters G (2010) Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 6(1):e1000715CrossRefPubMedGoogle Scholar
  25. 25.
    Gosbell IB, Mercer JL, Neville SA, Crone SA, Chant KG, Jalaludin BB et al (2001) Non-multiresistant and multiresistant methicillin-resistant Staphylococcus aureus in community-acquired infections. Med J Aust 174:627–630PubMedGoogle Scholar
  26. 26.
    Riley TV, Pearman JW, Rouse IL (1995) Changing epidemiology of methicillin-resistant Staphylococcus aureus in Western Australia. Med J Aust 163:412–414PubMedGoogle Scholar
  27. 27.
    Tong SY, Bishop EJ, Lilliebridge RA, Cheng AC, Spasova-Penkova Z, Holt DC et al (2009) Community-associated strains of methicillin-resistant staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes. J Infect Dis 199(10):1461–1470CrossRefPubMedGoogle Scholar
  28. 28.
    Badiou C, Dumitrescu O, Croze M, Gillet Y, Dohin B, Slayman DH et al (2008) Panton-Valentine leukocidin is expressed at toxic levels in human skin abscesses. Clin Microbiol Infect 14(12):1180–1183CrossRefPubMedGoogle Scholar
  29. 29.
    Croze M, Dauwalder O, Dumitrescu O, Badiou C, Gillet Y, Genestier AL et al (2009) Serum antibodies against Panton-Valentine leukocidin in a normal population and during Staphylococcus aureus infection. Clin Microbiol Infect 15(2):144–148CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • G. R. Nimmo
    • 1
    • 2
    • 4
  • J. M. Schooneveldt
    • 1
  • J. L. Sutherland
    • 1
  • S. Power
    • 1
  • D. Olesen
    • 3
  • C. Selvey
    • 3
  • F. Beard
    • 3
  • M. Jones
    • 3
  • D. L. Paterson
    • 1
    • 2
    • 3
  1. 1.Department of MicrobiologyPathology Queensland Central LaboratoryBrisbaneAustralia
  2. 2.University of Queensland Centre for Clinical ResearchHerstonAustralia
  3. 3.Communicable Diseases Branch, Queensland HealthHerstonAustralia
  4. 4.Pathology Queensland Central Laboratory, Herston Hospitals ComplexHerstonAustralia

Personalised recommendations